It is important that all stages of the audit be given an equal measure of attention.
L. Winberry, PhD
Advertisement
L. Winberry, PhD, is a senior consultant at Biologics Consulting Group.
Articles by L. Winberry, PhD
Advertisement
Latest Updated Articles
Effective Auditing of CMOsApril 2nd 2010
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5